Dolby Laboratories (DLB) Common Equity (2009 - 2026)

Dolby Laboratories (DLB) has reported Common Equity for 18 consecutive years, with $2.6 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity fell 0.82% year-over-year to $2.6 billion; the trailing twelve-month figure through Jun 2026 stood at $2.6 billion (down 0.82% YoY), and the FY2025 full-year result was $2.6 billion, up 5.83% from the prior year.
• Common Equity retreated to $2.6 billion in Q2 2026 per DLB's latest filing, from $2.6 billion in the prior quarter.
• Across five years, Common Equity topped out at $2.6 billion in Q3 2025 and bottomed at $2.3 billion in Q3 2022.
• Historically, Common Equity has averaged $2.5 billion across 5 years, with a median of $2.5 billion in 2022.
• The sharpest annual moves came in 2022 and 2025: Common Equity fell 13.56% in 2022, then climbed 6.82% in 2025.
• Over 5 years, Common Equity stood at $2.3 billion in 2022, then climbed by 3.04% to $2.4 billion in 2023, then rose by 6.55% to $2.5 billion in 2024, then advanced by 3.41% to $2.6 billion in 2025, then slipped by 0.39% to $2.6 billion in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $2.6 billion, $2.6 billion, and $2.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.